GlassScriptPhysician profile
Gaurav K Singh
NPI 1598908675
$7,086.18
in general payments reported to CMS, 2019-2025
27 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $193 · 2021: $487 · 2022: $265 · 2023: $1,558 · 2024: $1,908 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,379 · Food and Beverage: $1,379 · Charitable Contribution: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,379.48 |
| Food and Beverage | $1,378.73 |
| Charitable Contribution | $1,090.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,901.23 | 2019-2025 | Lensx, Clareon, Acrysof Iq Panoptix Uv Iol |
| Carl Zeiss Meditec USA, INC. | $1,347.50 | 2024 | Cirrus Hd-Oct, Visumax, Veracity Surgical |
| Microsurgical Technology, INC. | $1,090.20 | 2025 | |
| Abbvie INC. | $253.02 | 2021-2024 | Durysta, Rinvoq, Ozurdex |
| Regeneron Healthcare Solutions, INC. | $227.29 | 2022-2024 | Libtayo, Dupixent, Eylea |
| Sight Sciences, INC. | $215.62 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $198.14 | 2019-2025 | |
| Allergan, INC. | $97.41 | 2020-2021 | |
| Harrow Eye, LLC | $79.74 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $79.37 | 2020-2021 | |
| Vyne Pharmaceuticals INC. | $70.31 | 2021 | |
| Bausch & Lomb Americas INC. | $66.73 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Genentech USA, INC. | $66.25 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $54.35 | 2019-2023 | Ilumya |
| Merck Sharp & Dohme LLC | $53.79 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $45.15 | 2021 | |
| Heidelberg Engineering, INC. | $35.34 | 2024-2025 | Spectralis |
| Astellas Pharma US INC | $29.39 | 2025 | Izervay |
| Dompe US, INC. | $27.98 | 2025 | Oxervate |
| New World Medical,INC. | $26.80 | 2022 | |
| Oyster Point Pharma, INC. | $26.08 | 2023 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $17.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.08 | 2021 | |
| Horizon Therapeutics Plc | $14.96 | 2023 | Tepezza |
| Akorn, INC. | $12.96 | 2020 | |
| Leo Pharma INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.